"Info-AF" Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms

Sponsor
Medical University of Vienna (Other)
Overall Status
Recruiting
CT.gov ID
NCT04299269
Collaborator
(none)
130
1
35.1
3.7

Study Details

Study Description

Brief Summary

The aim of this project is to identify a variable that discerns patients who are interested in their disease (atrial fibrillation/atrial flutter) from patients who show no interest and furthermore test this theory in a questionnaire survey.

This should help distinguish between patients who are interested in shared decision making and patients who are not (further projects planned).

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
130 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
"Info-AF" Information Preferences in Patients With Atrial Fibrillation/Flutter and the Association With Clinical Symptoms
Actual Study Start Date :
Feb 28, 2020
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Feb 1, 2023

Outcome Measures

Primary Outcome Measures

  1. Preferences for autonomy measured with questionnaire [through study completion, an average of 1 year]

    Potential predictors of the outcome are clinical symptoms. Additional covariables will be patient characteristics including age and gender and disease characteristics. Regression analysis will be used as the main statistical method. Descriptive statistics and graphs and inferential statistics will be used as appropriate.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Current atrial fibrillation/flutter

  • 18 years of age

  • sufficient knowledge of the german language to fill out the questionnaire

Exclusion Criteria:
  • < 18 years of age

  • insufficient knowledge of the german language to fill out the questionnaire

  • Hemodynamic instability

Contacts and Locations

Locations

Site City State Country Postal Code
1 AKH Wien Vienna Austria 1090

Sponsors and Collaborators

  • Medical University of Vienna

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nikola Schütz, Principal Investigator, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT04299269
Other Study ID Numbers:
  • 1617/2019
First Posted:
Mar 6, 2020
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022